Women's Health Solutions Market Analysis Report 2022: Disruptive Technologies and Competitive Intensity are Driving Innovations in the Medtech Industry
August 10, 2022 05:58 ET
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Women's Health Solution Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. As the healthcare industry moves toward the...
Worldwide Infertility Drugs Industry to 2027 - Featuring Abbott Laboratories, Bayer and Mankind Pharma Among Others
April 11, 2022 07:23 ET
|
Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
$31+ Billion Worldwide Gynecology Drugs Industry to 2030 - Identify Growth Segments for Investment
November 11, 2021 06:53 ET
|
Research and Markets
Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Gynecology Drugs Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. This report...
Insights on the Menopause Global Market to 2026 - Featuring Abbvie, Allergan and Bayer Among Others
November 04, 2021 08:13 ET
|
Research and Markets
Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "Menopause Market Research Report by Treatment, Distribution Challenge, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has...
Global HER2+ Breast Cancer Market Will Expand to 12.1 Billion in 2030
September 21, 2021 05:43 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. Breast cancer is...
Global Drug Forecast and Market Analysis for HER2-Negative Breast Cancer to 2028
November 09, 2020 08:13 ET
|
Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "HER2-Negative Breast Cancer: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. Human...